NSABP FOUNDATION, INC.
Clinical Trials
66
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (57 trials with phase data)• Click on a phase to view related trials
A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
- Conditions
- Colo-rectal Cancer
- Interventions
- First Posted Date
- 2025-07-10
- Last Posted Date
- 2025-07-10
- Lead Sponsor
- NSABP Foundation Inc
- Target Recruit Count
- 79
- Registration Number
- NCT07058012
A Single Arm Phase II Study to Evaluate Treatment With Gevokizumab in Patients With Stage II/III Colon Cancer Who Are ctDNA-positive After Curative Surgery and Adjuvant Chemotherapy
- First Posted Date
- 2022-01-05
- Last Posted Date
- 2022-11-04
- Lead Sponsor
- NSABP Foundation Inc
- Registration Number
- NCT05178576
- Locations
- 🇺🇸
UF Health Davis Cancer Pavilion and Shands Med Plaza, Gainesville, Florida, United States
🇺🇸University of Iowa, Iowa City, Iowa, United States
🇺🇸Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast Cancer
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2018-08-14
- Last Posted Date
- 2022-04-20
- Lead Sponsor
- NSABP Foundation Inc
- Target Recruit Count
- 24
- Registration Number
- NCT03628066
- Locations
- 🇺🇸
Breast Cancer Care Specialist, Fountain Valley, California, United States
🇺🇸Orange Coast Blood and Cancer Care, Fountain Valley, California, United States
🇺🇸Saddleback Memorial Medical Center, Laguna Hills, California, United States
Study of Pembrolizumab With Pemetrexed and Oxaliplatin in Chemo-Refractory Metastatic Colorectal Cancer Patients
- Conditions
- Metastatic Colorectal Cancer
- Interventions
- Dietary Supplement: Folic AcidDietary Supplement: Vitamin B-12
- First Posted Date
- 2018-08-13
- Last Posted Date
- 2022-06-10
- Lead Sponsor
- NSABP Foundation Inc
- Target Recruit Count
- 33
- Registration Number
- NCT03626922
- Locations
- 🇺🇸
UF Health Davis Cancer Pavilion & Shands Medical Plaza, Gainesville, Florida, United States
🇺🇸Cancer Care Specialists of Central Illinois, Decatur, Illinois, United States
🇺🇸Decatur Memorial Hospital, Decatur, Illinois, United States
Study of Neratinib +Trastuzumab or Neratinib + Cetuximab in Patients With KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer by HER2 Status
- Conditions
- Metastatic Colorectal Cancer
- Interventions
- First Posted Date
- 2018-03-08
- Last Posted Date
- 2022-03-31
- Lead Sponsor
- NSABP Foundation Inc
- Target Recruit Count
- 35
- Registration Number
- NCT03457896
- Locations
- 🇺🇸
Kaiser Permanente-Anaheim, Anaheim, California, United States
🇺🇸Kaiser Permanente-Baldwin, Baldwin Park, California, United States
🇺🇸Kaiser Permanente-Bellflower, Bellflower, California, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 14
- Next